Verona Pharma plc buy Roth Capital
Start price
18.06.25
/
50%
€0.51
Target price
18.06.26
€100.90
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 18.06.26. The prediction end date can be changed by Roth_Capital at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Verona Pharma plc | - | - |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Roth_Capital for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) had its "buy" rating re-affirmed by analysts at Roth Capital. They now have a $116.00 price target on the stock, up previously from $92.00.
Ratings data for VRNA provided by MarketBeat